On Tuesday, February 6, 2024, Epic Research published the results of a dual-team Cosmos study, highlighting that taking certain glucagon-like peptide-1 (GLP-1) receptor agonists may reduce the chances...
On Monday, February 5, 2024, a research letter published in Hypertension highlighted the benefit of tirzepatide in managing high blood pressure using data from the SURMOUNT study. The letter notes a...
Earlier this week, the Biden–Harris administration announced its plans to address the expensive price tag of sickle cell disease, looking for a way to widen access despite the cost. In an...
On January 24, 2024, Azurity Pharmaceuticals sent an announcement to the United States FDA recalling Zenzedi, a brand name for 30 mg dextroamphetamine sulfate tablets, for mislabeled packaging. The...
On Tuesday, January 30, 2024, Vertex Pharmaceuticals issued a press release announcing that VX-548, its non-opioid pain management drug, effectively reduced pain compared to the placebo across multiple...
Earlier this week, Epic Research published a dual-team Cosmos study assessing how stopping glucagon-like peptide-1 (GLP-1) receptor agonists, sometimes called GLP-1 drugs, can impact long-term weight...
Solidifying the connection between healthcare and climate change, a survey by the Commonwealth Fund revealed that nearly 80% of clinicians in the United States believe that their hospitals must address...
Last week, the New York State Department of Health published a press release informing the public about charges against a Nassau County midwife who falsified vaccination records.
"Misrepresenting or...
On January 17, 2024, the National Institutes of Health (NIH) issued a media advisory announcing the results of a proof-of-concept identifying three antibodies that protect against various human...
On January 17, 2024, CVS Health published the Rx Report: The Future of Community Pharmacy Open Doors to Healthier Communities, which evaluated a survey in collaboration with the Harris Poll and used it...
On January 16, 2024, the Mayo Clinic Diet, a weight loss program developed and approved by the Mayo Clinic, announced the beta launch of the Mayo Clinic Diet Medical Weight Loss Rx Program. The growing...
Yesterday, on January 11, 2024, the United States FDA issued a drug safety communication updating the public on an ongoing investigation of glucagon-like peptide-1 receptor agonists. The administration...
On January 5, 2024, the United States FDA published an announcement detailing a voluntary recall of multiple intravenous (IV) drugs manufactured by Leiters Health. The release notes that 33 lots of IV...
In a groundbreaking investigation, the BBC uncovered a concerning trend in the online pharmaceutical industry, where prescription-only medicines are sold without adequate checks. The report exposes a...
Yesterday, January 4, 2024, Eli Lilly and Company issued a press release announcing the launch of LillyDirect. The platform is a digital healthcare tool for managing and supporting patients with...
According to a study published in Obesity, semaglutide effectively triggers weight loss in severely obese patients, including those who have had bariatric surgery to manage weight but have not yielded...
Last week, just before the end of 2023, Reuters published an article breaking a story from data analyzed by 3 Axis Advisors, a healthcare research firm. The analysis evaluated anticipated drug price...
On December 18, 2023, researchers published a study in Cancer, a journal of the American Cancer Society, evaluating the safety, feasibility, and efficacy of psilocybin-assisted group therapy to manage...
In an announcement published on December 18, 2023, Novo Nordisk, headquartered in Copenhagen, Denmark, announced its plans to allocate $260 million to research and develop vaccines for airborne...
AllianceRx Walgreens Pharmacy, a leading specialty and home delivery pharmacy in the United States and a subsidiary of Walgreens, has been selected as one of four specialty pharmacies to distribute...
